Traditionally a discipline based on physiology for the functionalassessment of patients with lung disease, pulmonary medicinehas been moving over the past decade into the realm of cellularand molecular biology in an attempt to unravel mechanisms ofdisease. Advances in understanding the pathogenesis of diseasessuch as cystic fibrosis, alpha1-antitrypsin deficiency, andasthma have resulted in changes in therapeutic strategy as wellas new and promising forms of treatment. At the same time, moresophisticated imaging methods have opened up a new world ofstructural characterization of disease. On the other hand, therespiratory complications of the . . . [Full Text of this Article]
Diagnostic Methods
Imaging Techniques
Assessment of Oxygenation
Genetic Disorders
Cystic Fibrosis
Alpha1-Antitrypsin Deficiency
Chronic Obstructive Pulmonary Disease
Asthma
Source Information
From the Pulmonary and Critical Care Division, Beth Israel Hospital, 330 Brookline Ave., Boston, MA 02215, where reprint requests should be addressed to Dr. Weinberger.
Portig, I., Wilke, A., Freyland, M., Wolf, M.-J., Richter, A., Ruppert, V., Pankuweit, S., Maisch, B.
(2006). Familial inflammatory dilated cardiomyopathy. Eur J Heart Fail
8: 816-825
[Abstract][Full Text]
Tarpy, S. P., Celli, B. R.
(1995). Long-Term Oxygen Therapy. NEJM
333: 710-714
[Full Text]
Metersky, M. L., Wlody, D., Cohen, G. N., Weinberger, S. E.
(1993). Recent Advances in Pulmonary Medicine. NEJM
329: 1278-1279
[Full Text]
Nakanishi, A., Morita, S., Iwashita, H., Sagiya, Y., Ashida, Y., Shirafuji, H., Fujisawa, Y., Nishimura, O., Fujino, M.
(2001). Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc. Natl. Acad. Sci. USA
98: 5175-5180
[Abstract][Full Text]